ArticleAdvances in therapy2025

Comparative Effectiveness of Valoctocogene Roxaparvovec and Efanesoctocog Alfa in the Treatment of Severe Hemophilia A: A Matching-Adjusted Indirect Comparison of Bleeding Frequency.

Thomas G Douglas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.